The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
December 25, 2002
John E. McDonough
Back to Publications
Organizations in the private and public sectors have in recent decades devised effective methods to eliminate or minimize hazards in such risk-laden activities as maintaining the health of astronauts in space, manufacturing automobiles, and preventing the transmission of food-borne disease. These methods, called proactive hazard analysis (or proactive risk assessment), could also protect the health and safety of patients and the health care workforce. The Veterans Health Administration (VHA) and the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) have begun to adapt proactive hazard analysis to hospital care.
ECRI and the Milbank Memorial Fund are collaborating to promote discussion about the use of proactive hazard analysis in health care settings. ECRI, a Collaborating Center of the World Health Organization, is a nonprofit medical technology assessment and risk management organization. Its work in proactive hazard analysis, building on more than three decades of analogous experience, is being applied in a variety of patient care settings in the United States and abroad. The Fund is an endowed philanthropic foundation, established in 1905, that works with decision makers in the public and private sectors on significant issues in policy for health care and public health. Fund staff learned about proactive hazard analysis in 2000, when senior policymakers in the U.S. Department of Agriculture requested their assistance in resolving issues that had arisen in the final stages of implementing its use to prevent food-borne illness as a result of the processing of meat, poultry, and eggs.
We convened clinicians, hospital leaders and health researchers, persons experienced in proactive hazard analysis, and representatives of four federal agencies, of state government, and of JCAHO. An earlier draft of this report was a background paper for this meeting. The author, John McDonough, a former legislative leader in Massachusetts, is currently a faculty member at Brandeis University and a program officer of the Fund. He has published books and articles on regulation in the health sector and on politics.
Participants in the meeting addressed the potential value of proactive hazard analysis to prevent pain and suffering among patients and persons who take care of them in hospital and ambulatory settings. We organized the agenda around three compelling issues: the safety of patients experiencing invasive procedures; preventing errors in ambulatory and home care; and reducing illness among patients with sensitive organs and immune systems. These questions received the most attention at the meeting:
This report summarizes the results of the meeting as well as the history of two approaches to proactive hazard analysis. During the meeting, we heard a consensus develop that either approach could improve the care of patients (though there were advocates of each of them), that it is not yet clear how best to introduce proactive hazard analysis into the health sector, and that because successful use of either approach should reduce reimbursement to treat the results of treatment errors, payers should offer providers financial incentives to introduce it.
We are grateful to the persons who reviewed the report, before and after the meeting. Reviewers who also attended the meeting are listed in the Appendix, other reviewers in the Acknowledgments.
Daniel M. FoxPresidentMilbank Memorial Fund
Jeffrey C. LernerPresident and CEOECRI
May 3, 2021
Apr 29, 2021
Apr 26, 2021
Get the Latest from the Milbank Memorial Fund
An endowed operating foundation that engages in nonpartisan analysis, collaboration, and communication, with an emphasis on state health policy.